Stay updated with breaking news from Cellular Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Ochsner Health and The University of Texas MD Anderson Cancer Center today announced a partnership to create Ochsner MD Anderson Cancer Center...
MyJournals.org - Science - 'Case report: Sudden onset optic neuritis shortly after SARS-CoV-2 vaccination in an allogeneic hematopoietic stem cell transplant recipient with chronic graft-vs.-host disease' (Frontiers in Medicine)
The University of Texas MD Anderson Cancer Center and Replay today announced that the Food & Drug Administration (FDA) has issued a 'safe to proceed' for the Investigational New Drug (IND) application for NY-ESO-1 TCR/IL-15 NK, an engineered T cell receptor natural killer (TCR NK) cell therapy for advanced synovial sarcoma and myxoid/round cell liposarcoma.
Investigators of the phase 1/2 KOMET-001 trial are seeking to address unmet needs in AML with the investigational menin inhibitor ziftomenib.
First clinical trial to explore the potential of imetelstat in relapsed/refractory acute myeloid leukemia and higher risk myelodysplastic syndromes Data from animal pre-clinical models... | June 13, 2023